Synopsis

Source of validity: Scientific
Rating (out of 5): 2

3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid is the IUPAC name for ferulic acid, a phenolic compound found in plant cell walls. There is some scientific evidence suggesting that ferulic acid possesses antioxidant, anti-inflammatory, and cytoprotective properties, which could, in theory, help mitigate certain chemotherapy-induced side effects. Preclinical studies (animal and in vitro) have shown that ferulic acid can reduce oxidative stress and ameliorate organ toxicity (such as nephrotoxicity and hepatotoxicity) caused by chemotherapy agents like cisplatin and doxorubicin. For example, studies have reported that ferulic acid supplementation reduced markers of oxidative damage and improved histological outcomes in animal models exposed to chemotherapeutic drugs.

However, direct clinical evidence in humans is very limited. Most available research comes from laboratory or animal studies, and there is a lack of rigorous, large-scale clinical trials validating the efficacy or safety of ferulic acid for reducing chemotherapy side effects in cancer patients. Thus, while a scientific rationale and some preliminary evidence exist, the support for its use in this context remains weak and primarily preclinical. More clinical research is needed before it can be recommended as a supportive treatment during chemotherapy.

More about 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid
More about Chemotherapy (reducing side effects)

Other ingredients used for Chemotherapy (reducing side effects)

Other health conditions supported by 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid

Products containing 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid